RG

Richard Gaster

Managing Partner at venBio Partners

San Francisco, California

Overview

Work Experience

vP

venBio Partners

  • Managing Partner

    2017 - Current

    venBio is a life sciences venture capital firm that partners with industry leaders to build game-changing medicines and technologies, with a focus on novel therapeutics for unmet medical needs.

3

35Pharma

  • Board Member

    2022

EB

Entact Bio

  • Board Member

    2021

A

Attralus

  • Board Member

    2020

AT

Arrakis Therapeutics

  • Board Member

    2019

SH

Swift Health Systems Inc.

  • Board Observer

    2019

AI

ACELYRIN, INC.

  • Board Member

    2021 - 2023

    IPO in May 2023 (NASDAQ: SLRN)

VB

Ventyx Biosciences

  • Board Member

    2021 - 2023

    IPO in October 2021 (NASDAQ: VTYX)

Education

Investments

Alumis

Series C

Total Funding: $330M

Attralus

Series A

Total Funding: $200M

Pharvaris

Series B

Total Funding: $220M

Entact Bio

Series A

Total Funding: $81M

Relevant Websites